Inhibrx Biosciences Inc. (INBX)
NASDAQ·Healthcare·Biotechnology
$71.48
-24.46%
Mkt Cap $1.37B
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$285.00
Range $245.00 – $325.00
Implied Upside
+298.7%
Consensus $285.00 vs current $71.48
NASDAQ·Healthcare·Biotechnology
$71.48
-24.46%
Mkt Cap $1.37B
No recent rating data.
Price Target (2 analysts)
$285.00
Range $245.00 – $325.00
+298.7%
Consensus $285.00 vs current $71.48